European stock markets opened higher as optimism grows over U.S.-China trade talks and a ceasefire between Iran and Israel, while the dollar hits a three-year low. Traders are betting on potential U.S. rate cuts.
A 19-year-old from Norfolk is the first in Europe to receive leniolisib, a groundbreaking treatment for her inherited disorder that could change her life after losing family to the disease.
The Philadelphia Sixers have drafted Johni Broome, a standout center from Auburn, with their second-round pick. After a stellar college career and a disappointing last season, Broome aims to prove his worth in the NBA.
New research reveals that ash trees in Britain are evolving resistance to dieback disease, offering hope for their survival after predictions of massive losses. Experts emphasize the importance of protecting and nurturing these resilient trees.
On the eve of the NBA draft, Shai Gilgeous-Alexander embraces his superstar status while 18-year-old Cooper Flagg emerges as America's hope in a league dominated by international talent. Can he restore the edge to American basketball?
Cooper Flagg, the standout forward from Duke, has been chosen as the No. 1 pick by the Dallas Mavericks in the NBA Draft, bringing hope to fans after the trade of superstar Luke Dončić. Flagg's impressive college stats and accolades signal a bright future for the franchise.
S&P 500 futures were nearly flat as investors hope the index can reach its all-time high. A recent rally, driven by falling oil prices amid a ceasefire between Iran and Israel, has kept the market resilient.
The Indiana Pacers defied expectations by reaching the NBA Finals, only to see their hopes dashed by Tyrese Haliburton's devastating injury. As they grapple with the aftermath, what does the future hold for this Cinderella team?
Markets in the Middle East saw a significant boost on Sunday following U.S. strikes on Iranian nuclear sites. Investors are optimistic that this might lead to a resolution in the ongoing conflict, particularly in Israel and Iran.
A groundbreaking HIV prevention shot, Yeztugo, has been approved by the FDA, offering hope for at-risk individuals with its twice-yearly injections. However, concerns about cost and accessibility remain.
